ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 18 Issue : 2 Year: 2017
Current Issue Archive Popular Article Ahead of Print

   
Quick Search





 
Inhibition of 5-lipoxygenase by zileuton in a rat model of myocardial infarction [Anatol J Cardiol]
Anatol J Cardiol. 2017; 17(4): 269-275 | DOI: 10.14744/AnatolJCardiol.2016.7248  

Inhibition of 5-lipoxygenase by zileuton in a rat model of myocardial infarction

Leyla Abueid1, Ünal Uslu4, Alev Cumbul4, Ayliz Velioğlu Öğünç3, Feriha Ercan2, İnci Alican1
1Departments of Physiology, Vocational School of Health Services, Marmara University; İstanbul-Turkey
2Histology and Embryology, Faculty of Medicine, Vocational School of Health Services, Marmara University; İstanbul-Turkey
3Department of Medical Laboratory Techniques, Vocational School of Health Services, Marmara University; İstanbul-Turkey
4Department of Histology and Embryology, Faculty of Medicine, Yeditepe University; İstanbul-Turkey

Objective: The goal of the present study was to investigate the effects of 5-lipoxygenase (5-LOX) inhibition, alone and with cyclooxygenase (COX) inhibitors, on inflammatory parameters and apoptosis in ischemia/reperfusion (I/R)-induced myocardial damage in rats. For this purpose, zileuton, a selective and potent inhibitor of 5-LOX, resulting in suppression leukotriene production, was used.
Methods: Male Wistar rats (200-250 g; n=12 per group) were used in the study. I/R was performed by occluding the left coronary artery for 30 minutes and 2 hours of reperfusion of the heart. Experimental groups were I/R group, sham I/R group, zileuton (5 mg/kg orally, twice daily)+I/R group, zileuton+indomethacin (5 mg/kg intraperitoneally)+I/R group, zileuton+ketorolac (10 mg/kg subcutaneously)+I/R group, and zileuton+nimesulide (5 mg/kg subcutaneously)+I/R group. Following I/R, blood samples were collected to measure tumor necrosis factor alpha (TNF-α), and left ventricles were excised for evaluation of microscopic damage; malondialdehyde (MDA), glutathione, nuclear factor (NF)-κB assays; and evaluation of apoptosis.
Results: Left ventricle MDA in I/R group was higher compared to sham group; however, it did not show significant change with zileuton. Although tissue injury in I/R group was less severe in all treatment groups, it was not statistically significant. NF-κB H-score and apoptotic index, which were higher in I/R group compared to sham I/R, were decreased with application of zileuton (H-score: p<0.01; apoptotic index: p<0.001). Zileuton had no significant effect on increased serum TNF-α levels in I/R group.
Conclusion: 5-LOX inhibition in rat myocardial infarction model attenuated increased left ventricle NF-κB expression and apoptosis and these actions were not modulated by COX inhibitors. (Anatol J Cardiol 2016; 16: 000-00)

Keywords: cyclooxygenase, ischemia/reperfusion, myocardial infarction, rat, zileuton, 5-lypoxygenase


Leyla Abueid, Ünal Uslu, Alev Cumbul, Ayliz Velioğlu Öğünç, Feriha Ercan, İnci Alican. Inhibition of 5-lipoxygenase by zileuton in a rat model of myocardial infarction. Anatol J Cardiol. 2017; 17(4): 269-275

Corresponding Author: İnci Alican, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2016 Turkish Society of Cardiology